Advertisement

Topics

PIramed Limited Company Profile

10:51 EDT 22nd June 2018 | BioPortfolio

PIramed was founded by Professor Michael Waterfield FRS (Ludwig Institute for Cancer Research, London), Professor Peter Parker (Cancer Research UK) and Professor Paul Workman (Institute of Cancer Research, London). To date, the Company has received £10m in equity and convertible loans from JPMorgan Partners and Merlin Biosciences.Principal intellectual property licences are to PI 3-kinase p110a (from the Ludwig Institute of Cancer Research) and to small molecule inhibitors of PI 3-kinase superfamily members (from the Institutes and Astellas Pharma). The Company became operational in August 2003 and is based in state-of-the-art laboratory premises in Slough, Berkshire, UK.

Location

957 Buckingham Avenue
Slough
Berkshire
SL1 4NL
United Kingdom

Contact

Phone: 44 (0)1753 285800
Fax: 44 (0)1753 568367
Email: General@piramed.com


News Articles [30 Associated News Articles listed on BioPortfolio]

Piramed Pharma: The Benefit of Focus

In this exclusive interview, Fintan Walton talks to Khatereh Ahmadi, Business Development Director at the UK biotech Piramed Pharma, about the company’s formation following a collaboration between Y...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Quotient Limited Reports Commencement of EU Blood Grouping Field Trial

JERSEY, Channel Islands, May 17, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validatio...

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for efti...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [83 Associated Companies listed on BioPortfolio]

PIramed Limited

PIramed was founded by Professor Michael Waterfield FRS (Ludwig Institute for Cancer Research, London), Professor Peter Parker (Cancer Research UK) and Professor Paul Workman (Institute of Cancer Rese...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "PIramed Limited" on BioPortfolio

We have published hundreds of PIramed Limited news stories on BioPortfolio along with dozens of PIramed Limited Clinical Trials and PubMed Articles about PIramed Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PIramed Limited Companies in our database. You can also find out about relevant PIramed Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record